Cited 0 times in
소아 신경 베체트병에서 효과적인 Infliximab 치료 사례
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김기환 | - |
dc.contributor.author | 김동수 | - |
dc.date.accessioned | 2015-12-28T11:01:30Z | - |
dc.date.available | 2015-12-28T11:01:30Z | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 2093-940X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/138530 | - |
dc.description.abstract | Behcet's disease is a systemic vasculitis, characterized by recurrent oral aphthous ulcers, recurrent genital ulcers, skin lesion, and ocular involvement. Monoclonal antibody to the tumor necrosis factor-α (TNF-α) is considered as a possible therapeutic approach to achieve clinical improvement, preventing relapse in Behcet's disease refractory to conventional anti-inflammatory drugs or immunosuppressive durgs. We report the use of infliximab, which is one of the TNF-α monoclonal antibodies, in a 17-year-old girl with Behcet's disease exhibiting severe mucocutaneous, ocular and neurological involvement refractory to standard treatment. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 209~213 | - |
dc.relation.isPartOf | Journal of Rheumatic Diseases | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | 소아 신경 베체트병에서 효과적인 Infliximab 치료 사례 | - |
dc.title.alternative | Successful Treatment of Child Neuro-Behcet’s Disease with Infliximab | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pediatrics (소아과학) | - |
dc.contributor.googleauthor | 허지애 | - |
dc.contributor.googleauthor | 김동수 | - |
dc.contributor.googleauthor | 김기환 | - |
dc.identifier.doi | 10.4078/jrd.2014.21.4.209 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00344 | - |
dc.contributor.localId | A00405 | - |
dc.relation.journalcode | J01737 | - |
dc.subject.keyword | Child | - |
dc.subject.keyword | Neuro-Behcet disease | - |
dc.subject.keyword | Infliximab | - |
dc.contributor.alternativeName | Kim, Ki Hwan | - |
dc.contributor.alternativeName | Kim, Dong Soo | - |
dc.contributor.affiliatedAuthor | Kim, Ki Hwan | - |
dc.contributor.affiliatedAuthor | Kim, Dong Soo | - |
dc.citation.volume | 21 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 209 | - |
dc.citation.endPage | 213 | - |
dc.identifier.bibliographicCitation | Journal of Rheumatic Diseases, Vol.21(4) : 209-213, 2014 | - |
dc.identifier.rimsid | 38363 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.